Compliance & EnforcementFalse Claims Act
ArchiveFalse Claims Act
3,592 articles from the Compliance & Enforcement Brief.
Articles
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
Relator Cannot Group Defendants Together Without Pleading Sufficient Allegations Against Each; U.S. District Court for the Northern District of Texas, Dallas Division, No. 3:16-CV-0803-S, U.S. ex rel. Emerson Park v. Legacy Heart Care LLC, et al.
Small Businesses and the FCA: Are More FCA Cases Against Small Businesses on the Horizon?
Remuneration? Not If It’s Fair Market Value, Says Eleventh Circuit
Heightened Pleading Standard Does Not Apply to Retaliation Claims; U.S. Court of Appeals for the District of Columbia Circuit, No. 18-7158, Sylvia Singletary D.V.M. v. Howard University
The FCA’s Reach Gets Longer: Private Equity Firms at Risk
Filing of Qui Tam Action Does Not Equate to Government Knowledge of Claims; U.S. District Court for the Northern District of West Virginia No. 5:19-CV-192, U.S. ex rel. Louis Longo v. Wheeling Hospital Inc., R&V Associates LTD., and Ronald L. Violi
The Ninth Circuit Expected to Rule that Doctors Can Be Wrong in the Winter v. Gardens False Claims Act Case
United States Settles with UPS for Overcharging Federal Agencies under GSA Contract
District Court Overturns Jury Decision, Finding No Whistleblowing Occurred; United States District Court for the Central District of California No. 2:17-cv-02538-CAS-SSx, David Lillie v. ManTech International Corp. et al.
Government Announces Million Dollar Settlement with Surety for Alleged Violations of False Claims Act
Qui Tam Defendants’ Presentations to Government During Investigation Unprotected from Discovery in Other Lawsuits, Federal District Court Ruled
Documents Provided to Government by Qui Tam Defendant Not Protected by Privilege; United States District Court for the District of Minnesota No. 11-cv-2453, United States and the State of California ex rel. Steven Higgins v. Boston Scientific Corp.
The Eleventh Circuit Remands AseraCare, But Affirms High Hurdle for Proving Falsity
Relator Failed to Sufficiently Plead its FCA Action by Relying on Big Data Alone, Resulting In Big Dismissal
Eleventh Circuit Shows the Way in Aseracare Decision: Why Mere Differences of Clinical Opinion Cannot Be Fraud Under the False Claims Act
Private Parties’ Ability to Sue Under FCA Does Not Extend to Unrelated Statutes or Abrogate State Immunity; United States Court of Appeals for the Third Circuit Nos. 19-1191 thru 19-1232, in re: PennEast Pipeline Company LLC
AseraCare 11th Circuit Case Holds Differences in Hospice Clinical Opinions Are Insufficient to Demonstrate Falsity Under the FCA
Eleventh Circuit Rules in AseraCare Case that Disagreements in Clinical Judgment, Without Objective Falsity, Do Not Prove Fraud Under the FCA
Relators Added in Amended Complaint Qualify as Original Sources, Even Though Disclosure to Government Occurred After Original Filing; United States District Court for the Eastern District of Texas, Sherman Division, No. 4:16-CV-00395, United States ex rel. Michael J. Fisher, et al. v. JP Morgan Chase Bank N.A.
Keep reading
